"Macugen is a pegylated anti-VEGF aptamer, which binds to vascular endothelial growth factor (VEGF)." Straight from an eyet PR, more of which is copied below. I didn't make one single comment on whether lucentis or macugen are better or not. I just pointed out that your yahoo poster is babbling incoherently and completely useless. FWIW, lucentis is an antibody that also binds to VEGF. VEGF=VEGF.
Macugen is indicated in the United States and Brazil for the treatment of neovascular age-related macular degeneration and in Canada for subfoveal choroidal neovascularization (CNV) secondary to neovascular AMD. Macugen is a pegylated anti-VEGF aptamer, which binds to vascular endothelial growth factor (VEGF). VEGF is a protein that plays a critical role in angiogenesis (the formation of new blood vessels) and increased permeability (leakage from blood vessels), two of the pathological processes that contribute to the vision loss associated with neovascular AMD